In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cognate BioServices Inc.

Latest From Cognate BioServices Inc.

Solutions Exist To Regenerative Medicine's Most Pressing Manufacturing Challenges

Experts share what they believe are the solutions to key manufacturing challenges, such as lowering cost of goods and centralized manufacturing, in the cell and gene therapy sector.

Manufacturing Gene Therapy

NewNeural LLC

While there, he found that when human bone marrow cells were treated in a unique way and implanted into an animal brain, the treated cells migrated throughout the brain and differentiated into human neurons. He also found that when these treated cells were implanted into a rodent eye with a damaged retina, the cells migrated to the area of damage and differentiated into new photoreceptor cells. Another discovery by Sugaya identified a small molecule that significantly increased the number of stem cells in the hippocampus and cortex of aged rats.


One Company's Distraction Is Another's Lead Product

Hoping to unfreeze investor attitudes toward the industry, biotechs are embracing product strategies with the enthusiasm of religious converts. Platforms are out; so, increasingly, is discovery. The clinic is in. Targacept and Layton Bioscience are both embracing this philosophy, which enabled their deal in which Targacept bought rights to a marketed small-molecule from cell therapist Layton.

BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Contract Research Organization-CRO
  • Pharmaceuticals
  • Services
  • Contract Manufacturing Organization
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • Cognate Therapeutics Inc